MAPKAP-1 Activators, as described here, refer to a class of compounds that can indirectly influence the activity of MAPKAP-1 by modulating various cellular processes and signaling pathways. These activators function by altering the cellular environment, secondary messenger systems, and gene expression patterns, which in turn can affect the function and regulation of MAPKAP-1. Compounds like Forskolin, EGF, and PMA play significant roles in activating or modulating cellular signaling pathways, particularly those involving adenylate cyclase, EGF receptor, and protein kinase C. These pathways are crucial for regulating processes such as cell growth, differentiation, and stress responses, where MAPKAP-1 is known to be involved. Similarly, agents like Retinoic Acid, Rapamycin, and Lithium Chloride can indirectly affect MAPKAP-1 by altering key signaling pathways and gene expression patterns related to cellular growth and the MAPK pathway.
Furthermore, natural compounds like Curcumin, Resveratrol, and Caffeic Acid Phenethyl Ester, known for their effects on cellular signaling, can also impact MAPKAP-1 activity. They modulate various aspects of cellular signaling and transcription regulation, indirectly influencing MAPKAP-1's role in these processes. Histone deacetylase inhibitors such as Trichostatin A and Sodium Butyrate contribute to the regulation of MAPKAP-1 activity by altering gene expression patterns related to MAPK signaling. Additionally, N-acetylcysteine, with its antioxidant properties, can impact MAPKAP-1 activity by affecting cellular redox balance.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which may indirectly influence MAPKAP-1 by modulating the cAMP-dependent pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can indirectly influence MAPKAP-1 by modulating MAPK pathway activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid can indirectly influence MAPKAP-1 by affecting gene expression and cellular differentiation processes associated with the MAPK pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, potentially influencing MAPKAP-1 activity indirectly by altering signaling pathways that intersect with the MAPK pathway. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can modulate various signaling pathways, potentially influencing MAPKAP-1 through its effects on MAPK signaling. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol can modulate signaling pathways, potentially affecting MAPKAP-1's role in cell signaling and stress responses. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate, by altering gene expression, may indirectly influence MAPKAP-1 activity through changes in cellular signaling pathways. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride can influence several signaling pathways and may indirectly influence MAPKAP-1 by altering the balance of secondary messengers. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
TSA, as a histone deacetylase inhibitor, can indirectly affect MAPKAP-1 by altering chromatin structure and gene expression linked to MAPK signaling. | ||||||
Caffeic acid phenethyl ester | 104594-70-9 | sc-200800 sc-200800A sc-200800B | 20 mg 100 mg 1 g | $71.00 $296.00 $612.00 | 19 | |
This compound can modify various signaling pathways, indirectly influencing MAPKAP-1 activity. | ||||||